Basis: Trailing twelve months (TTM net income over TTM revenue). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the net profit margin high or low?
The net profit margin of -9.79% is 55% below its 5-year average of -6.32%, near the high end of its 5-year range (-315.71%–41.71%).
246.90% below its 12-month average of -2.82%.
Reported quarterly profit margin; no daily interpolation. Q2 FY2026 (2026-06-30): -3.70%.
NET PROFIT MARGIN
-9.79%
NET PROFIT MARGIN AVG TTM
-2.82%
NET PROFIT MARGIN AVG 3Y
-8.81%
NET PROFIT MARGIN AVG 5Y
-6.32%
NET PROFIT MARGIN AVG 10Y
N/A
NET PROFIT MARGIN AVG 15Y
N/A
NET PROFIT MARGIN AVG 20Y
N/A
CURRENT VS TTM AVG
-246.90%
CURRENT VS 3Y AVG
-11.16%
CURRENT VS 5Y AVG
-54.86%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-0.26%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
-3665.38%
vs the sector median at left
SkinHealth Systems Inc.
Market Cap
$75.95M
Net Profit Margin
-9.79%
TTM Avg
-2.82%
3Y Avg
-8.81%
5Y Avg
-6.32%
Market Cap
$75.18M
Net Profit Margin
-55.03%
TTM Avg
-63.48%
3Y Avg
-81.34%
5Y Avg
-87.39%
Market Cap
$76.74M
Net Profit Margin
-63.06%
TTM Avg
-90.45%
3Y Avg
-113.67%
5Y Avg
-137.76%
Market Cap
$77.54M
Net Profit Margin
-155404.38%
TTM Avg
-155404.38%
3Y Avg
-155404.38%
5Y Avg
-155404.38%
Market Cap
$78.07M
Net Profit Margin
-130000.00%
TTM Avg
-89627.13%
3Y Avg
-49555.20%
5Y Avg
-36262.68%
Market Cap
$78.29M
Net Profit Margin
-47475.71%
TTM Avg
-41070.98%
3Y Avg
-27618.26%
5Y Avg
-38759.83%
Market Cap
$78.59M
Net Profit Margin
-12.91%
TTM Avg
-907.67%
3Y Avg
-691.25%
5Y Avg
-536.96%
Market Cap
$73.27M
Net Profit Margin
-210.75%
TTM Avg
-289.10%
3Y Avg
-513.23%
5Y Avg
-2388.54%
Market Cap
$72.83M
Net Profit Margin
-105.29%
TTM Avg
-106.48%
3Y Avg
-112.00%
5Y Avg
-95.88%
| NAME | MARKET CAP | NET PROFIT MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | $75.95M | -9.79% | -2.82% | -8.81% | -6.32% |
| Pulmonx Corporation (LUNG)vs › | $75.18M | -55.03% | -63.48% | -81.34% | -87.39% |
| Outset Medical, Inc. (OM)vs › | $76.74M | -63.06% | -90.45% | -113.67% | -137.76% |
| Neonc Technologies Holdings, Inc. (NTHI)vs › | $77.54M | -155404.38% | -155404.38% | -155404.38% | -155404.38% |
| Inovio Pharmaceuticals, Inc. (INO)vs › | $78.07M | -130000.00% | -89627.13% | -49555.20% | -36262.68% |
| Sera Prognostics, Inc. (SERA)vs › | $78.29M | -47475.71% | -41070.98% | -27618.26% | -38759.83% |
| vTv Therapeutics Inc. (VTVT)vs › | $78.59M | -12.91% | -907.67% | -691.25% | -536.96% |
| Hyperfine, Inc. (HYPR)vs › | $73.27M | -210.75% | -289.10% | -513.23% | -2388.54% |
| MindWalk Holdings Corp. (HYFT)vs › | $72.83M | -105.29% | -106.48% | -112.00% | -95.88% |
| Verrica Pharmaceuticals Inc. (VRCA)vs › | $72.32M | -102.84% | -531.21% | -660.25% | -488.89% |
Operating Margin
-1.5%
Net Profit Margin
-9.8%
Net Profit Margin = Net Income / Revenue
Net profit margin is the percentage of revenue that becomes net income after all expenses, taxes, and interest.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | NET PROFIT MARGIN |
|---|---|
| 2026-06-30 | -3.70% |
| 2026-03-31 | -10.17% |
| 2025-12-31 | -9.84% |
| 2025-09-30 | -15.61% |
| 2025-06-30 | 25.21% |
| 2025-03-31 | -14.51% |
| 2024-12-31 | -12.37% |
| 2024-09-30 | -23.21% |
| 2024-06-30 | 0.22% |
| 2024-03-31 | -0.83% |
| 2023-12-31 | -9.71% |
| 2023-09-30 | -75.78% |
| 2023-06-30 | 2.86% |
| 2023-03-31 | -23.48% |
| 2022-12-31 | 3.89% |
| 2022-09-30 | -0.09% |
| 2022-06-30 | 6.10% |
| 2022-03-31 | 41.71% |
| 2021-12-31 | -22.23% |
| 2021-09-30 | -315.71% |
| 2021-06-30 | -209.57% |
| 2021-03-31 | -6.89% |
| 2020-12-31 | -19.78% |
| 2020-09-30 | -6.41% |
| 2020-06-30 | -73.65% |
| 2020-03-31 | -27.88% |
| 2019-12-31 | 5.10% |
